Literature DB >> 28202167

Acute changes in glomerular filtration rate with renin-angiotensin system (RAS) inhibition: clinical implications.

Matthew R Weir1.   

Abstract

Renin-angiotensin system inhibition with either angiotensin-converting enzyme inhibitors or angiotensin receptor blockers has been shown to be effective in reducing progression of renal and cardiovascular disease. However, these medications are often associated with an initial reduction of estimated glomerular filtration rate, which is thought to be functional but may be of clinical significance. Newer insights from secondary analyses of large clinical trials may provide important clinical perspective.
Copyright © 2016 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28202167     DOI： 10.1016/j.kint.2016.11.019

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


  6 in total

1.  Association of Acute Increases in Plasma Creatinine after Renin-Angiotensin Blockade with Subsequent Outcomes.

Authors:  Edouard L Fu; Marco Trevisan; Catherine M Clase; Marie Evans; Bengt Lindholm; Joris I Rotmans; Merel van Diepen; Friedo W Dekker; Juan-Jesus Carrero
Journal:  Clin J Am Soc Nephrol       Date:  2019-08-08       Impact factor: 8.237

2.  Acute Declines in Renal Function during Intensive BP Lowering and Long-Term Risk of Death.

Authors:  Elaine Ku; Joachim H Ix; Kenneth Jamerson; Navdeep Tangri; Feng Lin; Jennifer Gassman; Miroslaw Smogorzewski; Mark J Sarnak
Journal:  J Am Soc Nephrol       Date:  2018-07-13       Impact factor: 10.121

3.  Angiotensin II type 1 receptor blockers decrease kynurenic acid production in rat kidney in vitro.

Authors:  Izabela Zakrocka; Katarzyna M Targowska-Duda; Artur Wnorowski; Tomasz Kocki; Krzysztof Jóźwiak; Waldemar A Turski
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2018-10-29       Impact factor: 3.000

4.  Clinical features of and risk factors for normoalbuminuric diabetic kidney disease in hospitalized patients with type 2 diabetes mellitus: a retrospective cross-sectional study.

Authors:  Qi Dai; Nan Chen; Ling Zeng; Xin-Jie Lin; Feng-Xiu Jiang; Xiong-Jie Zhuang; Ze-Yuan Lu
Journal:  BMC Endocr Disord       Date:  2021-05-22       Impact factor: 2.763

Review 5.  Diabetic kidney disease: new clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on "The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function".

Authors:  Giuseppe Pugliese; Giuseppe Penno; Andrea Natali; Federica Barutta; Salvatore Di Paolo; Gianpaolo Reboldi; Loreto Gesualdo; Luca De Nicola
Journal:  J Nephrol       Date:  2020-02       Impact factor: 3.902

6.  Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers on Acute Kidney Injury in Emergency Medical Admissions.

Authors:  Athanasios Feidakis; Maria-Rosa Panagiotou; Emmanouil Tsoukakis; Dimitra Bacharaki; Paraskevi Gounari; Petros Nikolopoulos; Katerina P Marathias; Sophia Lionaki; Demetrios Vlahakos
Journal:  J Clin Med       Date:  2021-01-22       Impact factor: 4.241
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.